U.S. Markets open in 1 hr 28 mins

Celgene and Biogen Analyst Moves Are 'Useless,' Jim Cramer Says

Jim Cramer

Morgan Stanley analysts upgraded shares of Biogen and downgraded shares of Celgene over concerns of generic drug pressures. TheStreet's Jim Cramer called these moves "useless."